Want to see LITS full AI Analyst Report?
Lite Strategy (LITS) Drug Pipeline
| Drug Name | Condition | Stage | Status | Study Name | Trial Start Date | Article |
|---|---|---|---|---|---|---|
| Voruciclib Monotherapy, Voruciclib And Venetoclax | Follicular Lymphoma (Fl), Small Lymphocytic Lymphoma (Sll), Marginal Zone Lymphoma (Mzl), Chronic Lymphocytic Leukemia (Cll), Acute Myeloid Leukemia (Aml), Mantle Cell Lymphoma (Mcl), Diffuse Large B-Cell Lymphoma (Dlbcl) | Phase I | Terminated | A Study of Voruciclib Alone or in Combination With Venetoclax in Subjects With B-Cell Malignancies or AML | May 24, 2018 | ― |
| Drug Name | Stage | Condition | Status | Study Name | Trial Start Date | Article |
|---|---|---|---|---|---|---|
| Voruciclib Monotherapy, Voruciclib And Venetoclax | Phase I | Follicular Lymphoma (Fl), Small Lymphocytic Lymphoma (Sll), Marginal Zone Lymphoma (Mzl), Chronic Lymphocytic Leukemia (Cll), Acute Myeloid Leukemia (Aml), Mantle Cell Lymphoma (Mcl), Diffuse Large B-Cell Lymphoma (Dlbcl) | Terminated | A Study of Voruciclib Alone or in Combination With Venetoclax in Subjects With B-Cell Malignancies or AML | May 24, 2018 | ― |
FAQ
What are the FDA phases for drug approval?
The FDA approval process for new drugs is divided into several phases: a. Preclinical testing b. Phase 1 – Safety and dosage c. Phase 2 – Effectiveness and side effects d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
What is a clinical trial?
A clinical trial is a carefully designed study in which researchers test a drug, treatment, or medical device in people to evaluate its safety, effectiveness, and potential side effects. These trials are essential for determining whether a new treatment should be approved for widespread use.
What drugs does Lite Strategy Inc (LITS) have in its pipeline
Lite Strategy LITS is currently developing the following drugs: Voruciclib Monotherapy, Voruciclib And Venetoclax. These drug candidates are in various stages of clinical development as the company works toward FDA approval.
